Q-omics provides the consensus-scored LINC02619 profile across patient tissues and cancer cell-line models. LINC02619 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, LINC02619 RNA expression shows 6,325 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LIHC, and STAD as cancer lineages where LINC02619 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for LINC02619 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes LINC02619 survival associations across molecular data types. LINC02619 RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

LINC02619 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	9	LIHC (57)	view →

This table ranks reproducible LINC02619 RNA expression–survival associations across cancer types. High LINC02619 expression shows unfavorable associations in LIHC, LUSC, ESCA, THCA, SKCM and THYM. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for LINC02619 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.467	0.784	<.001	57	view →
LUSC	OS	Tertile	II,III,IV	0.133	0.732	<.001	36	view →
ESCA	DFS	Tertile	All	0.148	0.673	.040	18	view →
THCA	DFS	Tertile	II,III,IV	0.514	0.884	.009	18	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	18	view →
THYM	DFS	Tertile	All	0.107	0.884	.001	18	view →

Pink = unfavorable, green = favorable. all 9 lineages →

LINC02619-LIHC (OS)

Kaplan–Meier survival curve for LINC02619 RNA expression in LIHC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with LINC02619 in patient tissues and cancer cell lines. In patient samples, LINC02619 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,325	STAD (6032)	view →
RNA	5,175	COAD (2121)	view →